ADAP $11.40 area Market Cap 1.1 Billion Investor Presentation (PDF Download Link) Recommended Reading Investors Website High of $19 per share in 2015 Cash 200 Million. Trials and Clinical work funded through mid 2020 We are a leader in the TCR T-cell therapy space focused on novel cancer immunotherapy products. We...
OSTK- near $47, recovering off 41 lows last week. Closing this out if it hits $40 per share, otherwise holding or you can buy from 41-46 This stock has been volatile obviously, first written up at $44 in the TPS service. We saw a high of $89...
35% Equity, 65% Cash in TPS Portfolio First off, I would like to apologize for lack up updates in the past week. I was unexpectedly out of town visiting my parents a few weeks ago for 9 days due to some medical issues with both of...
We have 5 positions open after taking a loss on SSC last week at 2.30 alert, now 1.55 area. Going back to the bad news there, the CEO and Chairman had iterated 300 million in revenues for the current fiscal year not once, but twice...
SSC- 2.35 The stock is getting hit as we get word that they changed Auditors via an 8-k filing late yesterday and then a few press releases this morning. One covering the change in Auditors and that is had nothing to do with any difference of...
We are updating the weekly charts and brief notes and annotations on all 6 open positions today. Due to recent volatile market conditions we have held off since the CDXC Report on any new positions, but are actively researching companies right now and will be adding...
Today we update weekly charts on the 6 open TPS Positions. Often when you zoom out to a weekly view you get better perspective, avoiding the noise of the day to day chops. We expect to add another company within 7 days or so to the...
Updating quick notes and thoughts on the 6 open TPS Positions Best Buys: JT under 7, CDXC 4.60-5, SSC under 3 JT -$6.72 a 13 week Post IPO base from $8 IPO. Insiders bought at $8 in the IPO and we continue to believe this stock has...
CDXC- $5 area We would suggest initial expected entry ranges from 4.60 to 5.40 area working your way in if possible. 275mm Market cap 50 Million Cash 57mm shares outstanding About ChromaDex: ChromaDex Corp. is an integrated, global nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research...
MARK- Taking the Loss due to uncertainty A nasty short piece hit out of the blue today and by the time we could post this up the stock is 5.80 down from 10.xx a few days ago. MARK has been putting out positive news of late but...
indian xxnx horny desi indian cheating slime wife show boobs in webcam.
